The population of the South Korea was about 50,767,000 in 2012. The main cause of death in Korea was cancer, cerebrovascular disease, cardiac disease, suicide, and diabetes in the order of frequency in 2011 \[[@B1]\]. Although average life expectancy of Korean was 81 years in 2011, healthy lifespan still remains low ([Fig. 1](#F1){ref-type="fig"}) \[[@B2]\]. There are four serious illnesses (cancer, cerebrovascular and cardiovascular illnesses, and rare hard-to-treat disease) which can be covered by insurance more than 95% in contrast to other disease 80%. That means the deductable (the amount patients pay for) stands at 20% for general illness, at 5% for the cancer, cerebrovascular and cardiovascular illnesses (only for surgery and recanalization), and at 10% for rare, hard-to-treat diseases \[[@B3]\].

Although expertise requires long period of medical training \[[@B4]\], neurointervention is one of the major medical f ield which progresses rapidly and can profoundly induce development of new devices or materials so that the neurointerventional procedure can affect health index in the era of longevity \[[@B5]\]. Therefore, we present current status of facilities, devices and trends of procedures related to this new medical field.

Number of Angiomachines
=======================

The number of angiomachines increased 5% in 2012 and 4% in 2013 nationwide due to continuous new installation ([Fig. 2](#F2){ref-type="fig"}). Installation number of angiomachine in each hospital depends on the scale of the hospital ([Fig. 3](#F3){ref-type="fig"}). Most angiomachines were installed in the tertiary or the general hospital which has more than 100 beds. There were overall 379 angiomachines; single 255 and biplane 124 in 2011.

Neurointerventional Devices and Materials
=========================================

The current insurance coverage and cost of neurointerventional devices and materials are shown in [Fig.4](#F4){ref-type="fig"}. Moma (Invatec, Roncadelle, Italy), Solitaire (EV3 Inc., CA, USA), drug eluting stent, and carotid protection device are not covered by insurance yet. Although stent-retriever like Solitaire can be very effective in clot removal in patients with acute stroke, there is no way to use it because generation of cost by using it is not allowed unless the device is allowed to be used by the Korean FDA and the insurance coverage is assessed by Health Insurance Review & Assessment Service. Nowadays the process takes almost two years if the medical methodology using the device is recognized as a new technology.

Trends of Case Number of Major Procedures
=========================================

Aneurysms
---------

There is increasing tendency of case number yearly ([Fig. 5](#F5){ref-type="fig"}). The reason of the increase can be explained by more detection of unruptured aneurysm rather than due to increased ruptured aneurysm. Although case number of clipping is still more than that of coiling, total clipping number decreased during the last two years in contrast to the continuous increase of coiling number. Therefore, the increasing trend of total number can be explained by increase of coiling number. It is expected that the number of coiling surpass the number of clipping in 2013.

The most procedures were performed in large cities ([Fig. 6](#F6){ref-type="fig"}). The case number of Seoul and Gyeonggi consisted of almost 50% of the total number. Such trend is similar in both coiling and clipping. However, clipping prevailed in some region as in Gwangju while coiling prevailed in Daejeon and Gyeongnam areas.

Stenting Procedures
===================

There is increasing tendency of overall stenting procedures in Korea. Cardiac stenting consisted of 86%, body 10% and brain (Neuro) only 4% of the total cases ([Fig. 7](#F7){ref-type="fig"}). Regarding neuro-stenting, extracranial procedures consisted of 73% and intracranial procedures 27% ([Fig. 8](#F8){ref-type="fig"}). Overall number of stenting procedures is recently stationary because the number of extracranial procedures increases while the number of intracranial procedures decreases.

In conclusion, the neurointerventional activities are increasing in every aspect of data including installation number of angiomachine and case number of procedures. In contrast to the needs and increasing tendency of the neurointerventional procedures, administrative process of the government takes rather long time in recognizing new medical technology and assessing effectiveness of the device and materials.
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